Alkermes to Take Part in the Fourth Annual Evercore ISI HealthCONx Conference

Rhea-AI Summary

Alkermes plc (Nasdaq: ALKS) announced its participation in the fourth annual Evercore ISI HealthCONx Conference on December 2, 2021, at 10:30 a.m. ET. The event will be accessible under the Investors section of Alkermes' website and archived for 14 days. Alkermes is a global biopharmaceutical company focused on developing innovative medicines in neuroscience and oncology, with a pipeline targeting neurodegenerative disorders and cancer.

Positive

• Participation in a significant industry conference may enhance visibility and investor interest.
• The company's focus on neuroscience and oncology indicates a strong commitment to innovative medical treatments.

Negative

• None.

DUBLIN, Nov. 24, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the fourth annual Evercore ISI HealthCONx Conference on Thursday, Dec. 2, 2021 at 10:30 a.m. ET (3:30 p.m. GMT). The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com. 

Contact:
Alex Braun
Investor Relations
+1 781 296 8493

View original content to download multimedia:https://www.prnewswire.com/news-releases/alkermes-to-take-part-in-the-fourth-annual-evercore-isi-healthconx-conference-301431308.html

SOURCE Alkermes plc

FAQ

What conference is Alkermes participating in?

Alkermes is participating in the fourth annual Evercore ISI HealthCONx Conference on December 2, 2021.

When will Alkermes' presentation be available?

The presentation will be available under the Investors section of the Alkermes website and archived for 14 days.

What is the focus of Alkermes plc?

Alkermes plc focuses on developing innovative medicines in neuroscience and oncology.

What time is Alkermes' presentation at the conference?

Alkermes' presentation will take place at 10:30 a.m. ET.

Where is Alkermes headquartered?

Alkermes is headquartered in Dublin, Ireland.